Abstracts are due on Friday!
Abstracts are due on Friday!
Conference Notes #5
Virtual Poster Contest - Abstracts are due Sept. 18
In conjunction with the Oct. 10 Virtual Conference, APPA will host its first ever Virtual Resident/Medical Student Poster Contest. Residents and students who are interested in participating are asked to coordinate with a faculty member in preparing a poster for the meeting. The posters are assigned abstract numbers and are published on the APPA website so count as “Published Abstracts” on your CV.  This is a very easy way to build your academic portfolio!  
The top scoring abstracts will be invited to present a virtual poster to be viewed and voted on by conference participants. The top three submissions will be awarded cash prizes.
Abstracts should be sent to Luke Engeriser, MD, lengeriser@altapointe.org, by Sept. 18 for consideration. See examples of abstracts at www.alabamapsych.org/abstracts
Specifications for virtual posters will be available soon.

Conference Spotlight: Implementation of Assisted Outpatient Treatment Program for Severely Mentally Ill Patients: Is it Feasible/Sustainable/Effective?
Praveen Narahari, MD, MS

Praveen Narahari, MD, MS, is assistant medical director for AltaPointe Health Systems He earned his medical degree from N.T.R. University of Health Sciences - Kakatiya Medical College, Warangal, India. He also obtained a master’s degree in community nutrition from Eastern Kentucky University. 
Before beginning his residency in adult psychiatry at the University of South Alabama he volunteered as research assistant at the University of Louisville, Department of Psychiatry. He served as chief resident of psychiatry during his PGY 4 year and received the Red Sash Award from the USA medical student class of 2015, 2016 and 2017. He received Faculty Teacher of the Year award from residents in 2018.  
Dr. Narahari’s special interests are in the area of biological psychiatry, community psychiatry and psychopharmacology. 
Dr. Narahari will present Implementation of Assisted Outpatient Treatment Program for Severely Mentally Ill Patients: Is it Feasible/Sustainable/Effective? at 10:45 a.m., Saturday, Oct. 10. 

Register Online
Print a Registration Form
Did you miss an issue of Conference Notes?
Past issues of Conference Notes are available on APPA's website. www.alabamapsych.com/physicians
Look Who's Coming
This list includes names of attendees whose registration was automatically transferred from the Spring Conference to the October virtual conference. If you are on the list and are unable to participate in the Oct. 10 conference, please let us know. Please check the list before registering for the Fall Conference.
Glenn Archibald, MD, Psychiatric Health Services, LLC, Birmingham
Amer Babi, UAB School of Medicine, Birmingham
Martha Tucker Ban, MD, Tuscaloosa VA Medical Center
Michael Banov, MD, PsychAtlanta, Marietta, GA
Pam Barnett, MD, Private Practice, Mobile
Nancy Bishop, BS, Alabama Department of Public Health, Montgomery
Emily Brewer, Mobile
W. Bogan Brooks, MD, AltaPointe Health Systems, Mobile
William Burns, AltaPointe Health Systems, Mobile
Gabrielle A. Carlson, MD, Renaissance School of Medicine at Stony Brook University, Stony Brook, NY
Jaria Chowdhury, MD, Alabama Psychiatry, Pelham
Marco Del Giudice, PhD, University of New Mexico Department of Psychiatry, Albuquerque, NM
J. Luke Engeriser, MD, AltaPointe Health Systems, Mobile
David R. Faber, MD, North Shelby Psychiatric Services, Helena
Jacqueline Feldman, MD, UAB, Birmingham
Andrew Friede, MD, MPH, FACPM, Grayson & Associates, Birmingham
Maria Hamilton, MD, AltaPointe Health Systems, Mobile
Deborah Hogan, MD, Retired
Shyla Hossain, University of South Alabama, Mobile
Amy Hudson, UAB - Huntsville
Tina Jackson, MD, University of South Alabama, Mobile
F. Cleveland Kinney, MD, PhD, University of Alabama - Birmingham
Jennifer Lamar, University of Alabama School of Medicine, Huntsville
Samantha Lee, University of South Alabama College of Medicine, Mobile
Fernando Lopez, MD, DLFAPA, SpectraCare, Dothan
Clinton Martin, MD, FAPA, UAB Huntsville Regional Medical Center
Jerlyn McCleod, MD, JC McCleod, MD, Psychiatric, PLLC, Dothan
Daniel Mejer, MD, Private Practice, Pike Road
Philip R. Muskin, MD, MA, DLFAPA, Columbia University Medical Center, New York, NY
Praveen Narahari, MD, MS, AltaPoine Health Systems, Daphne
Charles Nevels, MD, Private Practice, Tuscaloosa
Janaki Nimmagadda, MD, UAB-Huntsville
Paul O'Leary, MD, FAPA, SHKO Medicine, LLC, Birmingham
Godehard Oepen, MD, PhD, DLFAPA, Grayson & Associates, Hoover
Abhilasha Pandey, MD, Charles Nevels, MD, Tuscaloosa
Sarah Peake, PharmD, Syneos Health - Jannsen Neuroscience, Atlanta, GA
Nicholas Rivers, UAB School of Medicine - Huntsville
Nathan Smith, MD, UAB, Birmingham
Terri Steele, MD, Eastside Mental Health Center, Birmingham
Lindsey Stewart, MD, USA Health System, Mobile
Anna Tucker, RN, Grandview in Birmingham, Tuscaloosa
Anson Varghese, DO, UAB, Birmingham
Tarak Vasavada, MD, Huntsville Hospital
Harold Veits, MD, Private Practice, Mobile
Stewart D. Waddell, MD, DLFAPA, Mind Matters, PC, Mountain Brook
Nawal Weaver, MD, Atrium Health, Charlotte, NC
David R. Williamson, PhD, Janssen Scientific Affairs, LLC, Mobile
Anupama Yedla, MD, UAB-Huntsville

Virtual Conference approved for CME
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Medical Association of the State of Alabama through the joint providership of the Medical Foundation of Alabama and the Alabama Psychiatric Physicians Association. The Medical Foundation of Alabama is accredited by the Medical Association of the State of Alabama to provide continuing medical education for physicians.

Designation Statement
The Medical Foundation of Alabama designates this live activity for a maximum of 6 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Learning Objectives
  • Name three different theories of obesity, explain the role of hypothalamic dysfunction in obesity, and name two new treatments.
  • Recall two historic examples of physician-assisted suicide approaches, two different legal principles, two ethical principles that apply, and two ways to respond to patients requesting assisted death.
  • Explain legal use and proper handling of PDMP information, describe existing legal restraints (related to HIPAA and state law), and name three case scenarios where they will use PDMP.
  • Define three potential causes of increased hospitalizations, and three interventions shown to reduce re-hospitalization rates of mentally ill patients.
  • Describe evolutionary aspects of at least three different mental illnesses, explain the FSD model, and apply the new diagnostic framework to their clinical practice.
  • Name criteria differentiating childhood bipolar disorder from DMDD, Fragile X syndrome, and anger overload, as well as name at least four DSM-5 differential diagnoses for children with severe outbursts, with the related specific and general treatments.
  • List at least two preventative strategies, two drug combination treatments, two clinical tests, and two administrative interventions in the approach and treatment of dementia.
  • Name at least 5 different evidence-based supplemental treatments and identify their psychiatric benefits, SEs and risks.
powered by emma
Subscribe to our email list.